Your email and its content will be used to provide you an answerto your message. You have the possibility to access, to modify, to rectify and to suppress any personal data concerning you.
To exercise this right, please click here.
Ipsen at a glance
The group in 2014
26 January 2016 - Paris (France)
Ipsen announces publication in Pediatrics of the results of the phase III randomized study showing the efficacy and safety of Dysport®…